News | April 28, 2023
Yasmin and Mirena to take back seat from Bayer’s future drug strategy, says GlobalData
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
The award recognizes and supports promising female scientists working in mass spectrometry
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
Subscribe To Our Newsletter & Stay Updated
